Illumina Joins WIN Consortium in Personalized Cancer Medicine
read more »
WIN Consortium Appoints Professor Waun Ki Hong as Special Advisor to Oversee Its Combined Targeted Triple-Therapy Strate ...
read more »
WIN Consortium Describes Development of SIMS Algorithm to Personalize NSCLC Triplet Therapies
read more »
HTG Enters Worldwide Innovative Networking (WIN) Consortium for Personalized Cancer Medicine
read more »



Subscribe to our newsletter:


"The WIN Consortium offers an opportunity to make an impact on personalized cancer therapy across the globe by increasing the number of patients having access to innovative clinical trials and treatment with the latest innovative drugs."

  - Dr. John Mendelsohn, Chairman

Ecancer tv interviews at the AACR Annual Meeting, April 2015

Ecancer tv interviewed Dr Razelle Kurzrock, Moores Cancer Center, San Diego, USA and and Prof Waun Ki Hong, The University of Texas MD Anderson Cancer Center, Houston, USA during the recent American Association for Cancer Research (AACR) Annual meeting in Philadelphia, USA, April 2015 to discuss the latest news of the WIN Consortium and the forthcoming annual WIN Symposium 29-30 June 2015.

WIN Symposium 2014: Interviews on ecancertv

A number of speakers at the WIN 2014 Symposium were interviewed by ecancertv, one of the WIN Symposium media partners. 
To watch these interviews, please click on the following link:

WIN Symposium 2014: Breakthrough Biomarker Investigation and Combination Therapies

In a recent interview, Dr John Mendelsohn (The University of Texas MD Anderson Cancer Center, Houston, USA), Dr Razelle Kurzrock (Moores Cancer Center, San Diego, USA) and Dr Mace Rothenberg (Pfizer Inc., New York, USA) discuss the goals of the WIN Consortium and how these fields are highlighted at the annual WIN Symposium.